Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

Allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective treatment in eradicating high-risk acute myeloid leukemia (AML). Here, we present data from a novel HLA-haploidentical HSCT protocol that addressed the 2 remaining major unmet medical needs: leukemia relapse and chronic...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Blood Adv
Κύριοι συγγραφείς: Pierini, Antonio, Ruggeri, Loredana, Carotti, Alessandra, Falzetti, Franca, Saldi, Simonetta, Terenzi, Adelmo, Zucchetti, Claudio, Ingrosso, Gianluca, Zei, Tiziana, Iacucci Ostini, Roberta, Piccinelli, Sara, Bonato, Samanta, Tricarico, Sara, Mancusi, Antonella, Ciardelli, Sara, Limongello, Roberto, Merluzzi, Mara, Di Ianni, Mauro, Tognellini, Rita, Minelli, Olivia, Mecucci, Cristina, Martelli, Maria Paola, Falini, Brunangelo, Martelli, Massimo Fabrizio, Aristei, Cynthia, Velardi, Andrea
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Hematology 2021
Θέματα:
Transplantation
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948281/
https://ncbi.nlm.nih.gov/pubmed/33646302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003739
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια